HomeGreater Than Icon
Arvee Laboratories (India) LtdGreater Than Icon
Arvee Laboratories (India) Ltd Financials
Company Logo

Arvee Laboratories (India) Ltd Financial Statement

Arvee Laboratories (India) Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Jun 2024
Revenue10.71
Operating Expense9.07
Net Profit0.94
Net Profit Margin8.78
Earning Per Share0.85
EBIDTA1.65
Effective Tax Rate19.51

Arvee Laboratories (India) Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Total Revenue Annual61.35
Operating Expenses Annual54.07
Operating Profit Annual8.63
Interest Annual0.39
Depreciation2.08
Net Profit Annual4.12
Tax Annual2.05

Arvee Laboratories (India) Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Cash Flow at the Beginning1.28
Cash Flow from Operations2.93
Cash Flow from Investing-1.26
Cash Flow from Financing-2.42
Cash Flow at the End0.54

Arvee Laboratories (India) Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
PBDIT Margin (%)14.08
PBIT Margin (%)10.69
PBT Margin (%)-16.73
Net PROFIT Margin (%)6.72
Return On Networth / Equity (%)15.85
Return On Networth /Employed (%)23.25
Return On Assets (%)14.57
Total Debt / Equity (X)0.08
Asset Turnover Ratio (%)2.17

Arvee Laboratories (India) Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2023
Fixed Assets Annual12.68
Total Current Assets Annual21.57
Non Current Assets Annual17.12
Total Shareholders Funds Annual28.06
Total Assets Annual38.69

Arvee Laboratories (India) Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Sep 19, 2024, Arvee Laboratories (India) Ltd has a market capitalization of 158.03 Cr. Value Research classifies it as a Micro-Cap company.
Yes, Arvee Laboratories (India) Ltd is debt-free with a debt-to-equity ratio of 0.03.
In FY 2023 , Arvee Laboratories (India) Ltd recorded a total revenue of approximately 30.35 Cr marking a significant milestone in the company's financial performance.
Arvee Laboratories (India) Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately 0.1% and -0.1% annually, respectively..
Arvee Laboratories (India) Ltd's current PE ratio is 150.50.
Arvee Laboratories (India) Ltd's ROCE averaged 14.4% from the FY ending March 2022 to 2024, with a median of 14.1%. It peaked at 22.3% in March 2023, reflecting strong capital efficiency over the period..
Arvee Laboratories (India) Ltd's latest EBIT is Rs. 2.08 Cr, surpassing the average EBIT of Rs. 4.15 Cr over the 5 years..